Read + Share
Amedeo Smart
Independent Medical Education
Ateya AM, Sabri NA. Angiotensin-converting enzyme inhibitors (ACEIs) and Angiotensin-receptor blockers (ARBs) benefits outweigh the risks in COVID-19 hypertensive patients. J Med Virol 2020 Nov 17. doi: 10.1002/jmv.26672.PMID: 33200431
Email
LinkedIn
Facebook
Twitter
Privacy Policy